Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q61952148)
Watch
English
Raltegravir: a new antiretroviral class for salvage therapy
scientific article published in The Lancet
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17434380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 December 2019
title
Raltegravir: a new antiretroviral class for salvage therapy
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17434380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 December 2019
main subject
raltegravir
1 reference
based on heuristic
inferred from title
author
Omar Sued
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17434380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 December 2019
author name string
Pedro Cahn
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17434380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 December 2019
language of work or name
English
0 references
publication date
1 April 2007
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17434380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 December 2019
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17434380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 December 2019
volume
369
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17434380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 December 2019
issue
9569
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17434380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 December 2019
page(s)
1235-1236
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17434380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 December 2019
cites work
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960571-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960571-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960571-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of integrase inhibitors in the treatment of HIV disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960571-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960571-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(07)60571-6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17434380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 December 2019
PubMed publication ID
17434380
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17434380
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434380%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
